Crescita Therapeutics Inc. announced the appointment of Mr. Serge Verreault as President and CEO of the Company effective April 2, 2018. Mr. Dan Chicoine will continue as Crescita's Executive chairman and to serve on the company's board of directors. Prior to joining Crescita in April 2017, Mr. Verreault worked at Valeant Canada for fourteen years in a variety of positions.

Most recently, Mr. Verreault was the Executive Director of Business Development and a member of the Operating Committee. During his tenure in this role, he also served as the General Manager of Laboratoire Dr. RenaudTM. Laboratoire Dr. Renaud is one of the product lines that Crescita acquired as part of the INTEGA Skin Sciences Inc. acquisition in September 2016.

Mr. Verreault has executed more than thirty licensing and acquisition deals acting in every step of the business development process, from lead generation to integration, and participated in some of the global deals for the Canadian operation at Valeant. Prior to joining Valeant, Mr. Verreault worked at Medicago Inc. and Dismed Inc.